ITabMed's aim of "Innovating for Life" continues, with a focus on the discovery and development of cancer immunotherapy treatments.
ITabMed is a clinical-stage biotech company located in Shanghai, China. The company was founded in 2020 and is registered in Lin Gang Sci-Tech City, Shanghai. It was a spin-off entity from the former “Generon BioMed Ltd.”. The company is focused on immunotherapy drug research and development to treat cancer.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 1, 2021 | Series A | $20M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Binhai Capital | — | Series A |